| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/24/1998 | WO1998041231A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 09/24/1998 | WO1998041192A1 The use of temperature to control the size of cationic liposome/plasmid dna complexes |
| 09/24/1998 | WO1998041090A1 Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment |
| 09/24/1998 | DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis |
| 09/24/1998 | DE19711803A1 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung mit 15-Deoxyspergualin Extension of the expression of transgenic proteins by immunomodulatory treatment with 15-deoxyspergualin |
| 09/24/1998 | DE19707273C1 Expressionsvektor zur dauerhaften Expression einer Fremd-DNA An expression vector for stable expression of a foreign DNA |
| 09/24/1998 | CA2285701A1 .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/24/1998 | CA2284193A1 The use of temperature to control the size of cationic liposome/plasmid dna complexes |
| 09/24/1998 | CA2283639A1 Methods and compositions for use in gene therapy for treatment of hemophilia |
| 09/24/1998 | CA2281738A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1998 | EP0866127A2 HE8AN36, a steroid hormone receptor homolog |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein |
| 09/23/1998 | EP0865493A2 Viral vectors |
| 09/23/1998 | EP0865490A1 Dna sequence encoding the tumor suppressor ing1 |
| 09/23/1998 | EP0865489A1 Modified vegf antisense oligonucleotides |
| 09/23/1998 | EP0865282A1 Chimeric antiviral agents which incorporate rev binding nucleic acides |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1194000A Methods for enhancement of protective immune responses |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193916A Gene preparations |
| 09/22/1998 | US5811632 Non-human mammalian model for human papillomavirus-induced disease |
| 09/22/1998 | US5811537 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811534 Purine-based compounds for inclusion into oligonucleotides |
| 09/22/1998 | US5811520 Human phospholipase inhibitor protein |
| 09/22/1998 | US5811407 Using alphaviruses as vectors containing immunogenic or therapeutic proteins; |
| 09/22/1998 | US5811406 Stabilized by adding cryoprotectant and lyophilizing; delivering to cell tissue |
| 09/22/1998 | US5811304 Nucleic acid molecules encoding retinoblastoma protein-interacting zinc finger proteins |
| 09/22/1998 | US5811301 In vitro method for producing differentiated universally compatible human blood cells |
| 09/22/1998 | US5811300 TNF-α ribozymes |
| 09/22/1998 | US5811297 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages |
| 09/22/1998 | US5811275 HIV-specific ribozymes |
| 09/22/1998 | US5811274 Depositing viral particles or carriers on cell growth support, contacting target cells; efficiency; |
| 09/22/1998 | US5811270 In vitro method for concerted integration of donor DNA molecules using retroviral integrase proteins |
| 09/22/1998 | US5811266 Methods for producing human insulin |
| 09/22/1998 | US5811245 Antibodies that specifically bind to ALK-7, a novel serine threonine kinase receptor |
| 09/22/1998 | US5811234 Methods and applications for efficient genetic suppressor elements |
| 09/22/1998 | US5811233 Screening for psoriasis susceptibility by determining in a nucleic acid sample the presence of a polymorphic marker linked with a gene for interleukin enhancer binding factor |
| 09/22/1998 | US5810888 Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 09/21/1998 | CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein |
| 09/21/1998 | CA2200633A1 Rapid production of autologous tumor vaccines |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/17/1998 | WO1998040509A1 Chimeric adenoviral coat protein and methods of using same |
| 09/17/1998 | WO1998040508A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | WO1998040507A1 Expression of a modified foamy virus envelope protein |
| 09/17/1998 | WO1998040502A1 Peptide-enhanced transfections |
| 09/17/1998 | WO1998040501A1 Vectors having enhanced expression, and methods of making and uses thereof |
| 09/17/1998 | WO1998040500A1 Vectors having enhanced expression and methods of making and uses thereof |
| 09/17/1998 | WO1998040499A1 Gene delivery to mucosal epithelium for immunization or therapeutic purposes |
| 09/17/1998 | WO1998040498A2 Immunoadhesins and methods of production and use thereof |
| 09/17/1998 | WO1998040493A1 Fiv vaccine |
| 09/17/1998 | WO1998040492A1 Compositions and methods for elimination of unwanted cells |
| 09/17/1998 | WO1998040487A1 Angiogenin receptor, compositions and methods related thereto |
| 09/17/1998 | WO1998040486A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040479A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | WO1998040105A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | WO1998040100A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 09/17/1998 | WO1998040064A1 Butyrate prodrugs derived from lactic acid |
| 09/17/1998 | WO1998040058A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/17/1998 | WO1998026046A3 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 09/17/1998 | WO1998019710A3 Delivery of nucleic acid material to target cells in biological systems |
| 09/17/1998 | WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 09/17/1998 | DE19716732A1 Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung Specific magnetosomes, processes for their preparation and their use |
| 09/17/1998 | DE19709186A1 Filtrationsverfahren zur Trennung von Viren Filtration methods for separating viruses |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283628A1 Chimeric adenoviral coat protein and methods of using same |
| 09/17/1998 | CA2283626A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | CA2283557A1 Use of nucleic acids containing unmethylated cpg dinucleotide as an adjuvant |
| 09/17/1998 | CA2283490A1 Fiv vaccine |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283108A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 09/17/1998 | CA2232751A1 Novel compounds |
| 09/16/1998 | EP0864652A1 Expression of a foamy virus envelope protein |
| 09/16/1998 | EP0864651A2 Promoter of the cdc25B gene, its preparation and use |
| 09/16/1998 | EP0864645A1 (-)-strand rna virus vector having autonomously replicating activity |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863987A2 Vectors and methods for gene transfer to cells |
| 09/16/1998 | EP0863984A1 Methods and compositions for the diagnosis and treatment of cancer |
| 09/16/1998 | EP0863913A1 A method to increase the density of antigen on antigen presenting cells |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863749A2 Complex cationic lipids |
| 09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
| 09/16/1998 | CN1193316A New cationic and polycationic amphiphiles, reagent containing same and their use |
| 09/16/1998 | CN1193280A Control of CD44 gene expression for therapeutic use |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5808030 Polypeptide |
| 09/15/1998 | US5808027 N-2 substituted purines in oligonucleotides |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808005 Medical diagnosis; vaccines |
| 09/15/1998 | US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 09/15/1998 | US5807757 Controlling particle size distribution |
| 09/15/1998 | US5807740 Regulators of UCP2 gene expression |
| 09/15/1998 | US5807708 Conservin nucleic acid molecules and compositions |